At Dexcom (Nasdaq:DXCM), one of the leaders in continuous glucose monitoring (CGM), innovation continues to roll on.

Lifeward (Nasdaq:LFWD) announced today that it received CE mark approval for its ReWalk 7 personal exoskeleton.

Dentsply Sirona (Nasdaq:XRAY) announced that it completed the evaluation of strategic alternatives for its Wellspect ...

Pulse Biosciences announced today that the FDA granted investigational device exemption (IDE) for its pulsed field ablation ...

Morphic Medical today announced positive findings from a study of its Reset device that targets the cause of obesity and type ...

Onward Medical announced today that it has received CE mark for its ARC-EX spinal cord stimulation (SCS) system.

Clearance makes Liberty the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot can now begin U.S. commercialization efforts to advance ...

Ronovo Surgical announced today that it closed its Series D financing round with a total investment of $67 million.

Galvanize Therapeutics announced today that it raised $100 million and appointed Doug Godshall as chair and CEO.

According to a report in Globes, Edwards Lifesciences agreed to acquire the remaining stake in Vectorious Medical ...

Philips today announced the introduction of a new telemetry platform aiming to address critical challenges in healthcare.

Olympus announced an exclusive global distribution deal with MacroLux Medical Technology to distribute single-use urology ...